2-amino-3,5-dihydroxyoctadecane

Known as: enigmol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The orally bioavailable 1-deoxy-sphingosine analog, Enigmol, has demonstrated anticancer activity in numerous in vivo settings… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2013
2013
INTRODUCTION AND OBJECTIVES: Retroviral replicating vectors (RRVs) represent a novel gene delivery platform that can achieve… Expand
Is this relevant?
2011
2011
Sphingoid bases are cytotoxic for many cancer cell lines and are thought to contribute to suppression of intestinal tumorigenesis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Enigmol is a synthetic, orally active 1-deoxysphingoid base analogue that has demonstrated promising activity against prostate… Expand
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2010
2010
An enantioselective synthesis of the four 2S-diastereomers of enigmol (2-amino-octadecane-3,5diols) from L-alanine is reported… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Proc Amer Assoc Cancer Res, Volume 47, 2006 3177 Studies to identify early markers of ovarian cancer to support the… Expand
Is this relevant?